Lymphocyte Activation
- Name
- Lymphocyte Activation
- Accession Number
- DBCAT005203
- Description
Not Available
- Drugs
Drug Drug Description Eftilagimod alfa Eftilagimod alfa is under investigation in clinical trial NCT02614833 (IMP321 (Eftilagimod Alpha) as Adjunctive to a Standard Chemotherapy Paclitaxel Metastatic Breast Carcinoma). - Drugs & Drug Targets
Drug Target Type